Pictured: Boris Mueller

Boris A. Mueller, MD, MPH

Radiation Oncologist

Titles

Director, Radiation Oncology, MSK Bergen

Clinical Expertise

Breast Cancer; Lung Cancer; Bladder Cancer; Prostate Cancer; Gynecologic Tumors, Sarcoma; CNS Tumors, Spine Tumors, Head & Neck Cancer

Share

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Monday through Friday, 8:00 a.m. to 6:00 p.m., (Eastern time)
Accepted Insurance Providers

Dr. Mueller accepts the following list of insurance providers. Select your insurance provider to see more details.

Aetna

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (City of NY retirees only, starting 7/1/23)

Payor Type:
In Network Coverage Type(s): PPO

Blue Cross Blue Shield Federal Employee Program

Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO

Blue Cross Blue Shield New York

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS

Blue Cross Health Plus

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Carrum Health

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

Cigna

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Connecticare

Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO

Emblem

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Emblem Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Emblem Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Empire Blue Cross Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO, DSN

Empire Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Fidelis

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO

Fidelis Managed Medicaid & HARP

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Fidelis Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO

First Health

Payor Type:
In Network Coverage Type(s): PPO

Healthfirst

Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Healthfirst Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO, PPO

Healthsmart

Payor Type: Commercial
In Network Coverage Type(s): PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

Payor Type: Commercial
In Network Coverage Type(s): HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Husky CT Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Magnacare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO

Medicare Part A&B (traditional Medicare)

Payor Type:
In Network Coverage Type(s): Federal Government

Multiplan/Beech Street/PHCS

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

MVP

Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP

Non-Participating Plans with Out of Network Benefits

Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

Payor Type:
In Network Coverage Type(s): TBD

Oscar

Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO

Oxford

Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO

Qualcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Straight NJ Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Straight NY Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Tricare

Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO

UMR

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS

United Healthcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

World Trade Center Health Program (WTC)

Payor Type: Commercial
In Network Coverage Type(s): State Government

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, Johns Hopkins School of Medicine (1998) MPH, Johns Hopkins School of Public Health

Residencies

Radiation Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Radiation Oncology

I am a radiation oncologist who cares for patients at Memorial Sloan Kettering Bergen. Our team approach allows my colleagues and me to deliver state-of-the-art care close to home. I see about 400 patients each year, and have been working at Memorial Sloan Kettering since I finished my residency training there in 2003.

Read more

I love working with patients in an institution where patient care, medical research, and cutting-edge technology intersect. I have a degree in electrical engineering and worked as an engineer before attending medical school at Johns Hopkins University. I was attracted to a field that was heavily dependent on technology but also involved a great deal of patient contact. Radiation oncology proved to be a great fit.

It’s an inspiring time in our field. Thanks to new advances, we can now use stereotactic radiation therapy to deliver highly precise doses of radiation that destroy tumors and spare healthy tissue. I have been involved in research on improving the quality of cancer care through telemedicine, which allows doctors to diagnose and treat disease remotely.

My research has more recently focused on implementing tattooless radiotherapy at MSKCC for breast cancer, prostate cancer, and spine tumors. With the use of a new optical monitoring system (AlignRT) on our radiation machines, we will soon be able to treat patients without relying on tattoos.  An additional research interest of mine is learning how to reduce the risk of radiation-associated secondary cancers.

All patients are nervous during their first appointment — that’s normal. I work very hard with our nursing staff to make a strong personal connection with everyone I meet. Once a patient is under my care, I will always be there for them, even many years later.

I work very hard with our nursing staff to make a strong personal connection with everyone I meet. Once a patient is under my care, I will always be there for them, even many years later.

-Dr. Mueller

Awards and Honors

  • Castle Connolly: America's Top Doctors (2023)

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all External Beam Radiotherapy Service, Regional Care Network doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Braunstein LZ, Gillespie EF, Hong L, Xu A, Bakhoum SF, Cuaron J, Mueller B, McCormick B, Cahlon O, Powell S, Khan AJ. Breast Radiation Therapy Under COVID-19 Pandemic Resource Contstraints-Approaches to Defer or Shorten From a Comprehensive Cancer Center in the US. Adv Radiat Oncol 2020.

Bitencourt A, Rossi Saccarelli C, Morris EA, Flynn J, Zhigang Z, Khan AK, Gillesphie E, Caholon O, Mueller B, Cuaron J, McCormick B, Powell S, Plitas G, Razavi P, Pinker K, Riedl C, Sutton E, Braunstein L. Regional Lymph Node Involvement Among Patients with De Novo Metastatic Breast Cancer. JAMA Netw Open 2020.

Fitzgerald K, Flynn J, Zhang Z, Cost Z, Mueller B, Gillespie EF, McCormick B, Khan A, Cahlon O, Powell S, Braunstein L. Patterns of Recurrence Among Higher-Risk Patient Receiving Daily External Beam APBI to 40Gy in 10 Fractions. Adv Radiat Oncol 2019.

Sillanpann J, Lovelock M, Mueller B. The effects of the orthopedic metal artifact reduction (O-MAR) algorithm on contouring and dosimetry of head and neck radiotherapy patients. Med Dosim 2019.

Ho AY, Ballangrud A, Li G, Gupta GP, McCormick B, Gewanter R, Gelblum D, Zinovoy M, Mueller B, Mychalczak B. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam IMRT in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation. IJROBP 2018

Fury MG, Sherman EJ, Rao SS, Wolden S, Smith-Marrone S, Mueller B, Ng KK, Dutta PR, Gelblum DY, Lee JL, Shen R, Kurz S, Katabi N, Haque S, Lee NY. Phase I Study of Weekly nab-Paclitaxel + Weekly Cetuximab + IMRT in patients with stage III-IVB Head and Neck Squamous Cell Carcinoma. Ann Oncol 2014; 3:689-94.

Song Y, Obcemea C, Mueller B, Mychalczak B. Image-Guided Volumetric Modulated Arc Therapy (IG-VMAT) for Prostate Cancer. IFMBE (International Federation for Medical and Biomedical Engineering) Proceedings 2012; Volume 37, 223-226.

Song Y, Mueller B, Obcemea C, Mychalczak B. Feasibility of Implementing Stereotactic Body Radiation Therapy Using a Non-commercial Volumetric Modulated Arc Therapy Treatment Planning System for Early Stage Lung Cancer. IEEE (Institute for Electronic and Electrical Engineers) Engineering in Medicine and Biology 2011; 409-412.

Mueller BA, Obcemea C, Lee J, Sim S. Pilot Study of a Radiation Oncology Telemedicine Platform. Journal of Radiation Oncology Informatics 2010; 2:1:20-30.

Song Y, Zhang P, Obcemea C, Mueller B, Burman C, Mychalczak B. Dosimetric Effects of Gantry Angular Acceleration and Deceleration in Volumetric Modulated Radiation Therapy. IFMBE (Proceedings, World Congress on Medical Physics and Biomedical Engineering 2009; 25/1: 1046-1050.

Song Y, Zhang P, Wang P, Obcemea C, Mueller B, Burman C, Mychalczak B. The Development of a Novel Radiation Treatment Modality – Volumetric Modulated Arc Therapy. IEEE-Engineering in Medicine and Biology 2009; 3401 – 3404.

Song Y, Mueller B, Chan M, Sim S, Mychalczak B, Huang X. A Hybrid Method for Reliable Registration of Digitally Reconstructed Radiographs and kV X-ray Images for Image-Guided Radiation Therapy for Prostate Cancer. SPIE (Society of Photo-Optical Instrumentation Engineers) Medical Imaging 2008; Vol. 6918.

Song Y, Huang X, Mueller B, Mychalczak B. Phase Impact Factor: A Novel Parameter for Determining Optimal CT Phase in 4D Radiation Therapy Treatment Planning for Mobile Lung Cancer. SPIE Medical Imaging 2008: Vol. 6918.

Li G, Citrin D, Camphausen K, Mueller B, Mychalczak B, Miller RW, Song Y. Advances in 4D Medical Imaging and 4D radiation therapy. Technology in Cancer Research and Treatment 2008; Vol.1, 67-81.

Song Y, Mueller B, Burman C, Mychalczak B. From intensity modulated radiation therapy to 4D radiation therapy – An advance in targeting mobile lung tumors. Conf Proc IEEE Med Biol Soc. 2007; 226-9.

Song Y, Mueller B, Burman C, Mychalczak B, Song Y. A model-aided segmentation in urethra identification based on an atlas human autopsy image for intensity modulated radiation therapy. Conf Proc IEEE Eng Med Biol Soc. 2007; 1:3532-5.

Yamada Y, Bhatia S, Zaider M, Cohen G, Donat M, Eastham J, Rabbani F, Schupak K, Lee J, Mueller B, Zelefsky MJ. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 2006; 5(3):157-64.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Boris A. Mueller discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures